SV8 Biotech Fund LP — Form D/A
SV8 Biotech Fund LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2026-06-29. $70.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-06-29
- Form: D/A
- Accession: 0002070013-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $70.0M
- Investors: 3
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-548769
Issuer
- Name: SV8 Biotech Fund LP
- CIK: 0002070013
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2025
- Address: 71 KINGSWAY 4-12 Regent Street, LONDON, X0, WC2B 6ST
- Phone: 44 20 7421 7081
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Kate Bingham | Related Person | London, X0 |
| James Costine | Related Person | London, X0 |
| - SV Health Managers LLP | Related Person | London, X0 |
| - SV8 Bio GP LLP | Director | London, X0 |
| - SV8 Bio GP LLP | Executive Officer | London, X0 |
| Kate Bingham | Executive Officer | London, X0 |
| - SV Health Managers LLP | Director | London, X0 |
| - SV Health Managers LLP | Executive Officer | London, X0 |
| - SV Health Managers LLP | Promoter | London, X0 |
| James Costine | Executive Officer | London, X0 |
Other filings by this issuer (1)
More